Kopper L, Bánkfalvi A, Mihalik R, Páloczi K, Benczur M, Lapis K
First Institute of Pathology and Experimental Cancer Research, Semmelweis Medical University, Budapest, Hungary.
Clin Exp Immunol. 1988 Nov;74(2):295-9.
Three human non-Hodgkin lymphomas of B-cell origin have been maintained as xenografts in artificially immunosuppressed mice. The long-term maintenance (3-5 years) resulted in no significant change in the morphology, DNA-index or cell surface markers of the tumors. Immunophenotyping revealed many similarities in the morphologically distinct lines. Light chain (lambda) restriction appeared in two lines (HT 58 and 130), but in the third line (HT 117) the co-expression of both light chains indicated the origin from light chain 'uncommitted' B cells. HT 117 was also different, expressing high transferrin-receptor activity, although it proliferates with practically the same rate as the other two lines. This study confirms the value of the xenograft system to approaching many tumor-specific problems.
三种起源于B细胞的人类非霍奇金淋巴瘤已在人工免疫抑制的小鼠体内作为异种移植瘤维持生长。长期维持(3至5年)后,肿瘤的形态、DNA指数或细胞表面标志物均未发生显著变化。免疫表型分析显示,在形态上不同的细胞系存在许多相似之处。两个细胞系(HT 58和130)出现轻链(λ)限制,但在第三个细胞系(HT 117)中,两条轻链的共表达表明其起源于轻链“未定型”B细胞。HT 117也有所不同,尽管它与其他两个细胞系的增殖速度几乎相同,但表达高转铁蛋白受体活性。这项研究证实了异种移植系统在解决许多肿瘤特异性问题方面的价值。